Members |
targetComponentId |
Patient reviewed |
Patient review (procedure) |
Patient reviewed |
Patient review (procedure) |
Patient reviewed at hospital |
Review at hospital (procedure) |
Patient reviewed at hospital |
Review at hospital (procedure) |
Patient triggered inspiratory assistance |
Pressure support ventilation (regime/therapy) |
Patient written birth plan |
Patient written birth plan (record artifact) |
Pauciarticular juvenile rheumatoid arthritis |
Juvenile idiopathic arthritis, oligoarthritis (disorder) |
Pauciarticular onset juvenile chronic arthritis |
Juvenile idiopathic arthritis, oligoarthritis (disorder) |
Peaceful environment |
Peaceful environment (finding) |
Peach - dietary |
Peach (substance) |
Peanut - dietary |
Peanut (substance) |
Pear - dietary |
Pear (substance) |
Pectobacterium chrysanthemi |
Dickeya chrysanthemi (organism) |
Pectoralis major myocutaneous flap plus rib |
Pectoralis major osteomyocutaneous flap of rib |
Pediatric food panel mix radioallergosorbent test |
Food mix specific IgE antibody measurement |
Pedicle flap reconstruction - action |
Flap reconstruction - action |
Pedicle transverse rectus abdominus flap |
Pedicle transverse rectus abdominis myocutaneous flap (substance) |
Pediculus humanus humanus |
Pediculus humanus |
Pediococcus urinae-equi |
Aerococcus urinaeequi (organism) |
Peeling - action |
Stripping - action |
Pegaptanib 0.3mg intravitreal injection solution 1mL prefilled syringe |
Pegaptanib (as pegaptanib sodium) 3.33 mg/mL solution for injection |
Peginterferon alfa-2a 135micrograms/0.5mL solution for injection prefilled syringe |
Product containing precisely interferon alfa-2a (as peginterferon alfa-2a) 270 microgram/1 milliliter conventional release solution for injection (clinical drug) |
Peginterferon alfa-2a 180micrograms/0.5mL solution for injection prefilled syringe |
Interferon alfa-2a (as peginterferon alfa-2a) 360 microgram/mL solution for injection |
Peginterferon alfa-2b 100micrograms powder and solvent for injection solution vial |
Interferon alfa-2b (as peginterferon alfa-2b) 100 microgram powder for solution for injection vial |
Peginterferon alfa-2b 100micrograms powder for solution for injection in prefilled pen |
Peginterferon alfa-2b only product in parenteral dose form |
Peginterferon alfa-2b 100micrograms powder+solvent for solution for injection in prefilled pen |
Peginterferon alfa-2b only product in parenteral dose form |
Peginterferon alfa-2b 120micrograms powder and solvent for injection solution vial |
Product containing precisely interferon alfa-2b (as peginterferon alfa-2b) 120 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
Peginterferon alfa-2b 120micrograms powder+solvent for solution for injection in prefilled pen |
Interferon alfa-2b (as peginterferon alfa-2b) 120 microgram powder for solution for injection pen |
Peginterferon alfa-2b 150micrograms powder and solvent for injection solution vial |
Product containing precisely interferon alfa-2b (as peginterferon alfa-2b) 150 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
Peginterferon alfa-2b 150micrograms powder+solvent for solution for injection in prefilled pen |
Interferon alfa-2b (as peginterferon alfa-2b) 150 microgram powder for solution for injection pen |
Peginterferon alfa-2b 50micrograms powder and solvent for injection solution vial |
Product containing precisely interferon alfa-2b (as peginterferon alfa-2b) 50 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
Peginterferon alfa-2b 50micrograms powder+solvent for solution for injection in prefilled pen |
Interferon alfa-2b (as peginterferon alfa-2b) 50 microgram powder for solution for injection pen |
Peginterferon alfa-2b 80micrograms powder and solvent for injection solution vial |
Product containing precisely interferon alfa-2b (as peginterferon alfa-2b) 80 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
Peginterferon alfa-2b 80micrograms powder+solvent for solution for injection in prefilled pen |
Interferon alfa-2b (as peginterferon alfa-2b) 80 microgram powder for solution for injection pen |
Pegvisomant 30mg powder for injection solution vial |
Pegvisomant 20 mg powder for solution for injection vial |
Pelvic contrast radiography |
Plain X-ray of pelvis with contrast (procedure) |
Pelvic contrast radiography |
Plain X-ray of pelvis with contrast (procedure) |
Pelvic exenteration, female |
Pelvic exenteration |
Pelvic lymphangiogram |
Fluoroscopic lymphangiography of pelvis with contrast (procedure) |
Pelvic lymphangiogram |
Fluoroscopic lymphangiography of pelvis with contrast (procedure) |
Pelvic lymphangiogram |
Fluoroscopic lymphangiography of pelvis with contrast (procedure) |
Pelvic lymphangiography, bilateral |
Fluoroscopic lymphangiography of bilateral pelvis with contrast (procedure) |
Pelvic soft tissue X-ray |
Plain X-ray of soft tissue of pelvis (procedure) |
Pelvic somatic dysfunction |
Somatic dysfunction |
Pelvis X-ray |
Plain X-ray of pelvis (procedure) |
Penetrating injury caused by glass |
Penetrating injury caused by glass fragment |
Penetrating injury due to glass |
Penetrating injury caused by glass fragment |
Penetrating wound of orbit without mention of foreign body |
Penetrating wound of orbit |
Penetrating wound of orbit without mention of foreign body |
Penetrating wound of orbit |
Penicillin G benzathine 300,000unit/mL injection |
Product containing precisely benzathine benzylpenicillin 300000 unit/1 milliliter conventional release suspension for injection (clinical drug) |
Penicillin antibacterial overdose |
Penicillin overdose |
Penicillin g benzathine 150000iu/penicillin g procaine 150000iu powder for injection solution vial |
Product containing precisely benzathine benzylpenicillin 150000 unit/1 milliliter and procaine benzylpenicillin 150000 unit/1 milliliter conventional release suspension for injection (clinical drug) |
Penicillin g benzathine 300,000unt/mL injection |
Product containing precisely benzathine benzylpenicillin 300000 unit/1 milliliter conventional release suspension for injection (clinical drug) |
Penicillin g benzathine 300,000unt/mL injection suspension 10mL vial |
Product containing precisely benzathine benzylpenicillin 300000 unit/1 milliliter conventional release suspension for injection (clinical drug) |
Penicillin g benzathine 300,000unt/mL injection suspension 1mL vial |
Product containing precisely benzathine benzylpenicillin 300000 unit/1 milliliter conventional release suspension for injection (clinical drug) |
Penicillin g benzathine 600,000unt/mL injection suspension 1mL vial |
Benzathine benzylpenicillin 600000 unit/mL suspension for injection |
Penicillin g benzathine 600,000unt/mL injection suspension 20mL vial |
Benzathine benzylpenicillin 600000 unit/mL suspension for injection |
Penicillin g benzathine 600,000unt/mL injection suspension 2mL vial |
Benzathine benzylpenicillin 600000 unit/mL suspension for injection |
Penicillin g benzathine 600,000unt/mL injection suspension 4mL vial |
Benzathine benzylpenicillin 600000 unit/mL suspension for injection |
Penicillin g benzathine 900000iu/penicillin g procaine 300000iu powder for injection solution vial |
Benzathine benzylpenicillin 900000 unit/mL and procaine benzylpenicillin 300000 unit/mL suspension for injection |
Penicillin g procaine 600,000unt/mL injection suspension 1mL vial |
Product containing precisely procaine benzylpenicillin 600000 unit/1 milliliter conventional release suspension for injection (clinical drug) |
Penicillin g procaine 600,000unt/mL injection suspension 4mL vial |
Product containing precisely procaine benzylpenicillin 600000 unit/1 milliliter conventional release suspension for injection (clinical drug) |
Penicillin poisoning NOS |
Poisoning caused by penicillin (disorder) |
Penicillin v potassium 500mg |
Product containing precisely phenoxymethylpenicillin (as phenoxymethylpenicillin potassium) 500 milligram/1 each conventional release oral tablet (clinical drug) |
Penicillin v potassium 500mg tablet |
Product containing precisely phenoxymethylpenicillin (as phenoxymethylpenicillin potassium) 500 milligram/1 each conventional release oral tablet (clinical drug) |
Penicillium mycetogenum |
Penicillium mycetomagenum |
Penicillium patulum |
Penicillium griseofulvum |
Penicillium rubrum |
Talaromyces purpureogenus (organism) |
Penicillium rubrum toxicosis |
Penicillium purpurogenum toxicosis (disorder) |
Penicilloyl G extract |
Product containing benzylpenicillin (medicinal product) |
Penicilloyl V extract |
Phenoxymethylpenicillin-containing product |
Penile disorders NOS |
Disorder of penis |
Penile disorders NOS |
Disorder of penis |
Pentamidine isethionate 300mg injection |
Pentamidine isetionate 300 mg powder for solution for injection vial |
Pentamidine isethionate 300mg/5mL nebulizer solution |
Product containing precisely pentamidine isethionate 60 milligram/1 milliliter conventional release solution for inhalation (clinical drug) |
Pentamidine isethionate 300mg/vial injection |
Pentamidine isetionate 300 mg powder for solution for injection vial |
Pentasa 1g/100mL retention enema |
Mesalazine only product in rectal dose form |
Pentastarch 10% infusion solution bottle |
Pentastarch 100 mg/mL solution for injection |
Pentastarch 10% injection solution bag |
Pentastarch 100 mg/mL solution for injection |
Pentastarch 10g/100mL conventional release solution for infusion 500mL bag |
Pentastarch 100 mg/mL solution for injection |
Pentastarch 10g/100mL injection |
Pentastarch 100 mg/mL solution for injection |
Pentastarch 10g/100mL intravenous solution 500mL bag |
Pentastarch 100 mg/mL solution for injection |
Pentastarch 6% in sodium chloride 7.2% conventional release solution for injection |
Product containing only pentastarch (medicinal product) |
Pentastarch 6% in sodium chloride 7.2% intravenous infusion |
Product containing only pentastarch (medicinal product) |
Pentastarch 6% infusion solution bottle |
Product containing precisely pentastarch 60 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Pentastarch allergy |
Non-allergic hypersensitivity to pentastarch |
Pentobarbital sodium 18.2mg/5ml elixir |
Product containing precisely pentobarbital sodium 3.64 milligram/1 milliliter conventional release oral solution (clinical drug) |
Pentobarbital sodium 20mg/5ml elixir |
Pentobarbital sodium 4 mg/mL oral solution |
Pentose shunt pathway |
Pentose shunt pathway |
Pentostatin 10mg injection |
Pentostatin 10 mg powder for solution for injection vial |
Pentosyltransferase |
Pentosyltransferase |
People's democratic republic of Yemen |
Yemen (geographic location) |
Pepsin specific extract |
Product containing pepsin A (medicinal product) |
Peptic reflux disease |
Gastro-esophageal reflux disease with esophagitis |
Peptic ulcer NOS |
Peptic ulcer |
Peptic ulcer NOS |
Peptic ulcer |
Peptide hydrolase |
Peptide hydrolase |
Peptostreptococcus hydrogenalis |
Anaerococcus hydrogenalis (organism) |
Peptostreptococcus lactolyticus |
Anaerococcus lactolyticus (organism) |
Peptostreptococcus magnus |
Finegoldia magna (organism) |
Peptostreptococcus octavius |
Anaerococcus octavius (organism) |